Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 2.4B | 2.3B | 2.5B |
Cost of revenue | 2.6B | 2.0B | 1.9B | 2.2B |
Gross profit | 430.6M | 362.0M | 339.8M | 373.9M |
Operating expense | ||||
Research & development | 143.9M | 140.7M | 139.3M | 139.3M |
Selling general and admin | 124.3M | 124.6M | 121.3M | 107.1M |
Other operating expenses | — | — | — | — |
Operating income | 162.4M | 96.6M | 79.2M | 127.5M |
Non operating interest income | ||||
Income | 22.7M | 23.1M | 18.5M | 20M |
Expense | 1.9M | 2.2M | 2.3M | 2.5M |
Other income expense | — | — | — | — |
Pretax income | 170.0M | 125.4M | 100.3M | 144.5M |
Tax provision | 6.1M | 8.5M | 6.5M | 3.8M |
Net income | 163.9M | 117.0M | 93.8M | 140.6M |
Basic EPS | 1.1 | 0.8 | — | 0.9 |
Diluted EPS | 1.1 | 0.8 | — | 0.9 |
Basic average shares | 153.2M | 152.5M | — | 151.2M |
Diluted average shares | 153.2M | 152.8M | — | 152.9M |
EBITDA | 261.0M | 214.8M | 187.3M | 231.5M |
Net income from continuing op. | 170.0M | 125.4M | 100.3M | 144.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |